Stock Analysis on Net

Pfizer Inc. (NYSE:PFE)

$24.99

Analysis of Inventory

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Inventory Disclosure

Pfizer Inc., balance sheet: inventory

US$ in millions

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Finished goods
Work-in-process
Raw materials and supplies
Inventories

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).


The annual financial data reveals specific patterns in inventory components over the five-year period from 2020 to 2024.

Finished Goods
The value of finished goods exhibited fluctuations during the period. It increased from 2,878 million USD in 2020 to 3,641 million USD in 2021, then declined to 2,603 million USD in 2022. Subsequently, it rose again to 3,495 million USD in 2023 and further to 3,775 million USD in 2024. Overall, the trend suggests volatility with a general upward movement towards the end of the period.
Work-in-Process
Work-in-process inventory showed a consistent upward trajectory. Starting at 4,430 million USD in 2020, it slightly decreased marginally to 4,424 million USD in 2021 but then increased steadily each year, reaching 5,519 million USD in 2022, 5,687 million USD in 2023, and 6,100 million USD in 2024. This indicates growing investment in goods under production.
Raw Materials and Supplies
This category experienced moderate variability. The value increased from 738 million USD in 2020 to 994 million USD in 2021, then declined to 859 million USD in 2022. It rose again in 2023 to 1,007 million USD before slightly decreasing to 976 million USD in 2024. Despite some fluctuations, the values remained higher than at the beginning of the period.
Total Inventories
The aggregated inventory value showed a clear upward trend. From 8,046 million USD in 2020, it rose to 9,059 million USD in 2021. Although it experienced a minor decline in 2022 to 8,981 million USD, the figure increased substantially thereafter, reaching 10,189 million USD in 2023 and 10,851 million USD in 2024. This overall growth in inventories suggests an increase in stockholding and possibly production scale over the period analyzed.

In summary, while finished goods and raw materials demonstrated some volatility, work-in-process and total inventories reflected a generally increasing pattern. This could indicate strategic inventory buildup or response to market demands and operational scaling within the company during these years.